Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

NCT00659126 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
40
Enrollment
OTHER
Sponsor class

Stopped Loss of funding

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators